(原标题:百奥赛图IPO:连年巨亏 10位高管薪酬合超2145万 还要2.5亿募资补流)《电鳗财经》文 / 李瑞峰2024年12月31日,百奥赛图(北京)医药科技股份有限公司(以下简称百奥赛图)上交所科创板IPO更新了招股说明书。招股书显示,百奥赛图成立于2009年,是一家临床前 CRO 以及生物医药企业,该公司基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务,并利用其...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.